医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy.

广告
第一作者: Andrew F,Berdel
第一单位: Department of Medicine A, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
作者单位: Department of Medicine A, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany. [1] Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany. [2] Department of Hematology and Oncology, Red Cross Hospital, Munich, Germany. [3] Department of Oncology, Hematology and Stem Cell Transplantation, Klinikum Osnabrück, Osnabrück, Germany. [4] Department of Medicine I, University Hospital Lübeck, Lübeck, Germany. [5] Department of Medicine II, University Hospital Frankfurt, Frankfurt, Germany. [6] Department of Hematology and Oncology, Klinikum Idar-Oberstein, Idar-Oberstein, Germany. [7] Department of Medicine III, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany. [8] Centre for Clinical Trials, University of Münster, Münster, Germany. [9] Department of Medicine A, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.;Department of Medicine, III, Hospital Leverkusen, Leverkusen, Germany. [10] Department of Medicine A, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany. christoph.schliemann@ukmuenster.de. [11]
DOI 10.1007/s00277-022-05025-0
PMID 36399194
发布时间 2023-04-26
提交
  • 浏览0
Annals of hematology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷